| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.NEUBIOREV.2007.04.004 |
| P698 | PubMed publication ID | 17544131 |
| P50 | author | Calum Sutherland | Q37834437 |
| Charlotte J Green | Q57336348 | ||
| Arlene Astell | Q59393223 | ||
| P2093 | author name string | Adam R Cole | |
| P433 | issue | 7 | |
| P921 | main subject | dementia | Q83030 |
| P304 | page(s) | 1046-1063 | |
| P577 | publication date | 2007-04-24 | |
| P1433 | published in | Neuroscience & Biobehavioral Reviews | Q15709986 |
| P1476 | title | Molecular connexions between dementia and diabetes | |
| P478 | volume | 31 |
| Q93013552 | Abelmoschus esculentus subfractions attenuate beta amyloid-induced neuron apoptosis by regulating DPP-4 with improving insulin resistance signals |
| Q34237746 | Accelerated progression from mild cognitive impairment to dementia in people with diabetes |
| Q34352928 | Amylin deposition in the brain: A second amyloid in Alzheimer disease? |
| Q36980453 | Anaesthesia generates neuronal insulin resistance by inducing hypothermia |
| Q37645147 | Apoptosis signal regulating kinase 1 (ASK1): potential as a therapeutic target for Alzheimer's disease |
| Q33594133 | Association between risk factors for vascular dementia and adiponectin |
| Q48201019 | Atorvastatin and pitavastatin reduce oxidative stress and improve IR/LDL-R signals in Alzheimer's disease |
| Q34286417 | Brain diabetic neurodegeneration segregates with low intrinsic aerobic capacity |
| Q37474214 | Brain signaling systems in the Type 2 diabetes and metabolic syndrome: promising target to treat and prevent these diseases |
| Q50802285 | Brain-derived neurotrophic factor plasma levels: relationship with dementia and diabetes in the elderly population. |
| Q48498076 | Changes in Brain 14-3-3 Proteins in Response to Insulin Resistance Induced by a High Palatable Diet |
| Q41882101 | Defective insulin signaling pathway and increased glycogen synthase kinase-3 activity in the brain of diabetic mice: parallels with Alzheimer's disease and correction by insulin |
| Q35858095 | Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline |
| Q41911189 | Diabetes Worsens Ischemia-Reperfusion Brain Injury in Rats Through GSK-3β. |
| Q34608998 | Diabetes mellitus and Alzheimer's disease: shared pathology and treatment? |
| Q33607787 | Diabetes mellitus and risk of dementia: A meta-analysis of prospective observational studies |
| Q37177378 | Dietary omega-3 fatty acid deficiency and high fructose intake in the development of metabolic syndrome, brain metabolic abnormalities, and non-alcoholic fatty liver disease |
| Q36034035 | Differential interaction of Apolipoprotein-E isoforms with insulin receptors modulates brain insulin signaling in mutant human amyloid precursor protein transgenic mice |
| Q39134632 | Geniposide decreases the level of Aβ1-42 in the hippocampus of streptozotocin-induced diabetic rats |
| Q37689883 | Insulin and Insulin-Sensitizing Drugs in Neurodegeneration: Mitochondria as Therapeutic Targets |
| Q64930788 | Integrative computational evaluation of genetic markers for Alzheimer's disease. |
| Q38938961 | Is Alzheimer's disease a Type 3 Diabetes? A critical appraisal |
| Q35687287 | Mechanisms of brain aging regulation by insulin: implications for neurodegeneration in late-onset Alzheimer's disease |
| Q46032053 | Metabolic links between diabetes and Alzheimer's disease. |
| Q98576875 | Metalloproteins and apolipoprotein C: candidate plasma biomarkers of T2DM screened by comparative proteomics and lipidomics in ZDF rats |
| Q34866029 | Mid- and late-life diabetes in relation to the risk of dementia: a population-based twin study |
| Q49015305 | Models of dementia: an introductory overview |
| Q37856779 | Molecular mechanisms linking diabetes mellitus and Alzheimer disease: beta-amyloid peptide, insulin signaling, and neuronal function |
| Q39401091 | Multiple Mechanisms Linking Type 2 Diabetes and Alzheimer's Disease: Testosterone as a Modifier. |
| Q39939775 | Nerve growth factor regulates the expression of the cholinergic locus and the high-affinity choline transporter via the Akt/PKB signaling pathway |
| Q37652713 | Obesity and insulin resistance are associated with reduced activity in core memory regions of the brain |
| Q36945266 | Predictors of cognitive decline in older individuals with diabetes |
| Q53290887 | Predictors of cognitive impairment and dementia in older people with diabetes. |
| Q89447564 | Quercetin protects against diabetic encephalopathy via SIRT1/NLRP3 pathway in db/db mice |
| Q47108734 | Rab-GTPase binding effector protein 2 (RABEP2) is a primed substrate for Glycogen Synthase kinase-3 (GSK3). |
| Q24307889 | Regional and cellular distribution patterns of insulin-degrading enzyme in the adult human brain and pituitary |
| Q38734515 | Selenoprotein S Reduces Endoplasmic Reticulum Stress-Induced Phosphorylation of Tau: Potential Role in Selenate Mitigation of Tau Pathology. |
| Q30586321 | Sex and ApoE genotype differences in treatment response to two doses of intranasal insulin in adults with mild cognitive impairment or Alzheimer's disease. |
| Q38396373 | T3D-959: A Multi-Faceted Disease Remedial Drug Candidate for the Treatment of Alzheimer's Disease |
| Q37164474 | Targeting Alzheimer's Disease Neuro-Metabolic Dysfunction with a Small Molecule Nuclear Receptor Agonist (T3D-959) Reverses Disease Pathologies |
| Q37900307 | Targeting amyloid-beta by glucagon-like peptide -1 (GLP-1) in Alzheimer's disease and diabetes |
| Q50444655 | The Research on the Relationship of RAGE, LRP-1, and Aβ Accumulation in the Hippocampus, Prefrontal Lobe, and Amygdala of STZ-Induced Diabetic Rats |
| Q35986310 | The Role of Insulin and Insulin-Like Growth Factor-1/FoxO-Mediated Transcription for the Pathogenesis of Obesity-Associated Dementia |
| Q36704319 | The case for conscientiousness: evidence and implications for a personality trait marker of health and longevity |
| Q83920033 | The effects of the Chinese medicine ZiBu PiYin recipe on the hippocampus in a rat model of diabetes-associated cognitive decline: a proteomic analysis |
| Q37245273 | The functional state of hormone-sensitive adenylyl cyclase signaling system in diabetes mellitus |
| Q26863763 | The impairment of insulin signaling in Alzheimer's disease |
| Q37765832 | The link between iron, metabolic syndrome, and Alzheimer's disease |
| Q28742884 | The ε3 and ε4 alleles of human APOE differentially affect tau phosphorylation in hyperinsulinemic and pioglitazone treated mice |
| Q24289511 | Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson’s, Huntington’s, Alzheimer’s, prions, bactericides, chemical toxicology and others as examples |
| Q92069383 | Transcriptomic and Network Analysis Highlight the Association of Diabetes at Different Stages of Alzheimer's Disease |
| Q37272936 | Treadmill exercise ameliorates Alzheimer disease-associated memory loss through the Wnt signaling pathway in the streptozotocin-induced diabetic rats |
| Q36490441 | Type 2 Diabetes as a Risk Factor for Dementia in Women Compared With Men: A Pooled Analysis of 2.3 Million People Comprising More Than 100,000 Cases of Dementia |
| Q26825253 | Type 2 diabetes and cognitive impairment: contributions from neuroimaging |
| Q34658239 | Uncontrolled diabetes increases the risk of Alzheimer's disease: a population-based cohort study |
| Q35073216 | Whole blood gene expression profiles in insulin resistant Latinos with the metabolic syndrome |
Search more.